Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × HER2-positive Breast Cancer × Protons × Clear all

Phase

Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1 HER2-positive Breast Cancer 1 Carcinoma, Hepatocellular 1

Interventions

Trastuzumab 3 pertuzumab 2 Docetaxel 2 palbociclib 1 Protons 1 Paclitaxel 1 Letrozole 1 Fulvestrant 1 Fluorodeoxyglucose F18 1 Enfuvirtide 1 Doxorubicin 1 Cyclophosphamide 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02345772 2018-02-20

Neohttp

Western Regional Medical Center

Phase 1/2 Terminated

4 enrolled 1 chart

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡